NASDAQ : ARPO

Aerpio Pharmaceuticals, Inc.

$2.2 USD

-$0.02 (-0.9%)

Volume
826.01K
Average Volume
401.78K
Market Capitalization
$53.67M
P/E Ratio
-1.31
Dividend Yield
0.00%
Price Target
Year High
$49.80
Year Low
$2.16
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$11.36
Company Overview

NASDAQ

Biotechnology

Healthcare

ARPO

12

US

USD

http://www.aerpio.com

15139851920

00810B105

0001422142

Liquidity Metrics

0.00

11.36

11.36

3.15

0.00

Sales & Valuation

$7.14M

0.00

1.31

-5.48

-0.14

Profitability

-$0.33

-$20.6M

0.00%

0.00%

-79.63%

-91.02%

P/E Metrics

-1.31

-0.01

-0.01

Analyst Price Target & Rating

N/A

0/5

4 Analysts

%

Poll Results

About Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) Stock

Aerpio Pharmaceuticals Inc., a biopharmaceutical enterprise headquartered in Blue Ash, Ohio, currently employs 27 full-time staff. The company's core mission revolves around the research and development of therapeutic solutions for ocular diseases. Its product pipeline is spearheaded by AKB-9778, with two additional programs, AKB-4924 and ARP-1536, also under development. AKB-9778 is a small molecule designed to activate the Tie-2 pathway, intended for the treatment of diabetic retinopathy (DR). AKB-4924, another candidate, functions as a selective stabilizer of hypoxia-inducible factor-1 alpha (HIF-1alpha) and is being investigated for its potential in treating inflammatory bowel disease (IBD). ARP-1536 is a humanized monoclonal antibody that targets the same pathway as AKB-9778. It opera ... tes by attaching to the extracellular domain of vascular endothelial protein tyrosine phosphatase (VE-PTP), thereby inhibiting its interaction with Tie-2. As of April 14, 2017, Aerpio had successfully concluded a Phase II clinical trial for AKB-9778, which involved 144 patients with diabetic macular edema. By the same date, a Phase Ia clinical trial for AKB-4924 in healthy volunteers had also been completed.

Frequently Asked Questions

What is the current Aerpio Pharmaceuticals, Inc. (ARPO) stock price?

Aerpio Pharmaceuticals, Inc.(NASDAQ:ARPO) stock price is $2.2 in the last trading session. During the trading session, ARPO stock reached the peak price of $2.3 while $2.16 was the lowest point it dropped to. The percentage change in ARPO stock occurred in the recent session was --0.9% while the dollar amount for the price change in ARPO stock was -$0.02.

ARPO's industry and sector of operation?

The NASDAQ listed ARPO is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of ARPO?

|
|
|
|
|

How many employees does ARPO have?

Number of ARPO employees currently stands at 12. ARPO operates from 9987 Carver Rd, Blue Ash, OH , US.

Link for ARPO official website?

Official Website of ARPO is: http://www.aerpio.com

How do I contact ARPO?

ARPO could be contacted at phone #15139851920 and can also be accessed through its website. ARPO operates from 9987 Carver Rd, Blue Ash, OH , US.

How many shares of ARPO are traded daily?

The average number of ARPO shares traded daily for last 3 months was 401.78K.

What is the market cap of ARPO currently?

The market value of ARPO currently stands at $53.67M with its latest stock price at $2.2